TD Cowen initiated coverage on shares of Standard BioTools (NASDAQ:LAB – Free Report) in a research report report published on Tuesday morning, Marketbeat.com reports. The firm issued a buy rating and a $3.50 price objective on the stock. Separately, Jefferies Financial Group initiated coverage on shares of Standard BioTools in a research report on Thursday, […]